JESSICA VOSSLER: Open Payments
NPI 1114461845 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 50 payments from 15 companies in 2025. Trend: 2023 $489 · 2024 $976 · 2025 $1,046
Food & beverage: $1,001Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $194 |
| Novo Nordisk Inc | 9 | $182 |
| AstraZeneca Pharmaceuticals LP | 6 | $169 |
| PFIZER INC. | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $93 |
| Exact Sciences Corporation | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $41 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $27 |
Products named: JARDIANCE, AIRSUPRA, PREVNAR 20, Wegovy, MOUNJARO, Ozempic, FARXIGA, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
